Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Sleep disorders, depression and anxiety are associated with adverse safety outcomes in healthcare workers: A prospective cohort study.

Weaver MD, Vetter C, Rajaratnam SMW, O'Brien CS, Qadri S, Benca RM, Rogers AE, Leary EB, Walsh JK, Czeisler CA, Barger LK.

J Sleep Res. 2018 Aug 1:e12722. doi: 10.1111/jsr.12722. [Epub ahead of print]

PMID:
30069960
2.

Reliability of the American Academy of Sleep Medicine Rules for Assessing Sleep Depth in Clinical Practice.

Younes M, Kuna ST, Pack AI, Walsh JK, Kushida CA, Staley B, Pien GW.

J Clin Sleep Med. 2018 Feb 15;14(2):205-213. doi: 10.5664/jcsm.6934.

3.

Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy.

Budhiraja R, Kushida CA, Nichols DA, Walsh JK, Simon RD, Gottlieb DJ, Quan SF.

Eur Respir J. 2017 Nov 30;50(5). pii: 1700348. doi: 10.1183/13993003.00348-2017. Print 2017 Nov.

PMID:
29191951
4.

Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials.

Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D.

Am J Geriatr Psychiatry. 2017 Jul;25(7):791-802. doi: 10.1016/j.jagp.2017.03.004. Epub 2017 Mar 8.

PMID:
28427826
5.

Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.

Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D.

Psychopharmacology (Berl). 2017 Jun;234(11):1703-1711. doi: 10.1007/s00213-017-4573-1. Epub 2017 Mar 7.

PMID:
28265715
6.

Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.

Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D.

J Clin Sleep Med. 2016 Sep 15;12(9):1215-25. doi: 10.5664/jcsm.6116.

7.

Outcomes of a Mobile Health Coaching Platform: 12-Week Results of a Single-Arm Longitudinal Study.

Willey S, Walsh JK.

JMIR Mhealth Uhealth. 2016 Jan 8;4(1):e3. doi: 10.2196/mhealth.4933.

8.

Impact of Randomization, Clinic Visits, and Medical and Psychiatric Cormorbidities on Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea.

Budhiraja R, Kushida CA, Nichols DA, Walsh JK, Simon RD, Gottlieb DJ, Quan SF.

J Clin Sleep Med. 2016 Mar;12(3):333-41. doi: 10.5664/jcsm.5578.

9.

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.

Herring WJ, Connor KM, Ivgy-May N, Snyder E, Liu K, Snavely DB, Krystal AD, Walsh JK, Benca RM, Rosenberg R, Sangal RB, Budd K, Hutzelmann J, Leibensperger H, Froman S, Lines C, Roth T, Michelson D.

Biol Psychiatry. 2016 Jan 15;79(2):136-48. doi: 10.1016/j.biopsych.2014.10.003. Epub 2014 Oct 23.

PMID:
25526970
10.

SMART DOCS: a new patient-centered outcomes and coordinated-care management approach for the future practice of sleep medicine.

Kushida CA, Nichols DA, Holmes TH, Miller R, Griffin K, Cardell CY, Hyde PR, Cohen E, Manber R, Walsh JK.

Sleep. 2015 Feb 1;38(2):315-26. doi: 10.5665/sleep.4422.

11.

Lack of Impact of Mild Obstructive Sleep Apnea on Sleepiness, Mood and Quality of Life.

Quan SF, Budhiraja R, Batool-Anwar S, Gottlieb DJ, Eichling P, Patel S, Shen W, Walsh JK, Kushida CA.

Southwest J Pulm Crit Care. 2014;9(1):44-56.

12.

Reception will recognize the extensive contributions of Professor Thomas Roth to the SRS and AASM.

Walsh JK, Drake CL, Badr MS.

Sleep. 2014 May 1;37(5):831-2. doi: 10.5665/sleep.3636. No abstract available.

13.

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.

Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ.

Lancet Neurol. 2014 May;13(5):461-71. doi: 10.1016/S1474-4422(14)70053-5. Epub 2014 Mar 27.

PMID:
24680372
14.

You still need more than CPAP for OSA patients to lose weight.

Quan SF, Budhiraja R, Clarke DP, Goodwin JL, Gottlieb DJ, Nichols DA, Simon RD, Smith TW, Walsh JK, Kushida CA, Phillips B.

J Clin Sleep Med. 2014 Mar 15;10(3):349. doi: 10.5664/jcsm.3552. No abstract available.

15.

Strategic opportunities in sleep and circadian research: report of the Joint Task Force of the Sleep Research Society and American Academy of Sleep Medicine.

Zee PC, Badr MS, Kushida C, Mullington JM, Pack AI, Parthasarathy S, Redline S, Szymusiak RS, Walsh JK, Watson NF.

Sleep. 2014 Feb 1;37(2):219-27. doi: 10.5665/sleep.3384. No abstract available.

16.

The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation.

Hall-Porter JM, Schweitzer PK, Eisenstein RD, Ahmed HA, Walsh JK.

J Clin Sleep Med. 2014 Jan 15;10(1):27-34. doi: 10.5664/jcsm.3352.

17.

The COMET Sleep Research Platform.

Nichols DA, DeSalvo S, Miller RA, Jónsson D, Griffin KS, Hyde PR, Walsh JK, Kushida CA.

EGEMS (Wash DC). 2014 Nov 24;2(1):1059. doi: 10.13063/2327-9214.1059. eCollection 2014.

18.

Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea.

Quan SF, Budhiraja R, Clarke DP, Goodwin JL, Gottlieb DJ, Nichols DA, Simon RD, Smith TW, Walsh JK, Kushida CA.

J Clin Sleep Med. 2013 Oct 15;9(10):989-93. doi: 10.5664/jcsm.3064.

19.

The critical role of sleep spindles in hippocampal-dependent memory: a pharmacology study.

Mednick SC, McDevitt EA, Walsh JK, Wamsley E, Paulus M, Kanady JC, Drummond SP.

J Neurosci. 2013 Mar 6;33(10):4494-504. doi: 10.1523/JNEUROSCI.3127-12.2013.

20.

Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, Simon RD Jr, Guilleminault C, White DP, Goodwin JL, Schweitzer PK, Leary EB, Hyde PR, Hirshkowitz M, Green S, McEvoy LK, Chan C, Gevins A, Kay GG, Bloch DA, Crabtree T, Dement WC.

Sleep. 2012 Dec 1;35(12):1593-602. doi: 10.5665/sleep.2226.

21.

The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey.

Shahly V, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC.

Arch Gen Psychiatry. 2012 Oct;69(10):1054-63. doi: 10.1001/archgenpsychiatry.2011.2188.

PMID:
23026955
22.

Strategies for de-identification and anonymization of electronic health record data for use in multicenter research studies.

Kushida CA, Nichols DA, Jadrnicek R, Miller R, Walsh JK, Griffin K.

Med Care. 2012 Jul;50 Suppl:S82-101. doi: 10.1097/MLR.0b013e3182585355. Review.

PMID:
22692265
23.

Insomnia, comorbidity, and risk of injury among insured Americans: results from the America Insomnia Survey.

Kessler RC, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK.

Sleep. 2012 Jun 1;35(6):825-34. doi: 10.5665/sleep.1884.

24.

Sleep: a health imperative.

Luyster FS, Strollo PJ Jr, Zee PC, Walsh JK; Boards of Directors of the American Academy of Sleep Medicine and the Sleep Research Society.

Sleep. 2012 Jun 1;35(6):727-34. doi: 10.5665/sleep.1846.

25.

Chronic insomnia, quality-of-life, and utility scores: comparison with good sleepers in a cross-sectional international survey.

Léger D, Morin CM, Uchiyama M, Hakimi Z, Cure S, Walsh JK.

Sleep Med. 2012 Jan;13(1):43-51. doi: 10.1016/j.sleep.2011.03.020. Epub 2011 Nov 16.

PMID:
22093806
26.

EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.

Ma J, Dijk DJ, Svetnik V, Tymofyeyev Y, Ray S, Walsh JK, Deacon S.

J Clin Sleep Med. 2011 Oct 15;7(5):493-501A. doi: 10.5664/JCSM.1316.

27.

Days-out-of-role associated with insomnia and comorbid conditions in the America Insomnia Survey.

Hajak G, Petukhova M, Lakoma MD, Coulouvrat C, Roth T, Sampson NA, Shahly V, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC.

Biol Psychiatry. 2011 Dec 1;70(11):1063-73. doi: 10.1016/j.biopsych.2011.08.010. Epub 2011 Oct 1.

PMID:
21962491
28.

Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon.

Greenblatt DJ, Harmatz JS, Walsh JK, Luthringer R, Staner L, Otmani S, Nedelec JF, Francart C, Parent SJ, Staner C.

Biopharm Drug Dispos. 2011 Dec;32(9):489-97. doi: 10.1002/bdd.773. Epub 2011 Sep 20.

PMID:
21935965
29.

Insomnia and the performance of US workers: results from the America insomnia survey.

Kessler RC, Berglund PA, Coulouvrat C, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK.

Sleep. 2011 Sep 1;34(9):1161-71. doi: 10.5665/SLEEP.1230. Erratum in: Sleep. 2011;34(11):1608. Sleep. 2012 Jun;35(6):725.

30.

Dedications honor sleep research and sleep medicine trailblazer Dr. William C. Dement.

Walsh JK, Strollo PJ.

Sleep. 2011 Sep 1;34(9):1147-8. doi: 10.5665/SLEEP.1220. No abstract available.

31.

Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS).

Walsh JK, Coulouvrat C, Hajak G, Lakoma MD, Petukhova M, Roth T, Sampson NA, Shahly V, Shillington A, Stephenson JJ, Kessler RC.

Sleep. 2011 Aug 1;34(8):997-1011. doi: 10.5665/SLEEP.1150.

32.

The association between insomnia severity and healthcare and productivity costs in a health plan sample.

Sarsour K, Kalsekar A, Swindle R, Foley K, Walsh JK.

Sleep. 2011 Apr 1;34(4):443-50.

33.

The association between obstructive sleep apnea and neurocognitive performance--the Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Quan SF, Chan CS, Dement WC, Gevins A, Goodwin JL, Gottlieb DJ, Green S, Guilleminault C, Hirshkowitz M, Hyde PR, Kay GG, Leary EB, Nichols DA, Schweitzer PK, Simon RD, Walsh JK, Kushida CA.

Sleep. 2011 Mar 1;34(3):303-314B.

34.

A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure.

Walsh JK, Griffin KS, Forst EH, Ahmed HH, Eisenstein RD, Curry DT, Hall-Porter JM, Schweitzer PK.

Sleep Med. 2011 Feb;12(2):147-52. doi: 10.1016/j.sleep.2010.06.011. Epub 2011 Jan 21.

PMID:
21256800
35.

Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey.

Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC.

Biol Psychiatry. 2011 Mar 15;69(6):592-600. doi: 10.1016/j.biopsych.2010.10.023. Epub 2010 Dec 31.

PMID:
21195389
36.

Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem.

Svetnik V, Ferri R, Ray S, Ma J, Walsh JK, Snyder E, Ebert B, Deacon S.

Sleep. 2010 Nov;33(11):1562-70.

37.

Reliability and validity of the brief insomnia questionnaire in the America insomnia survey.

Kessler RC, Coulouvrat C, Hajak G, Lakoma MD, Roth T, Sampson N, Shahly V, Shillington A, Stephenson JJ, Walsh JK, Zammit GK.

Sleep. 2010 Nov;33(11):1539-49.

38.

Associations of nonrestorative sleep with insomnia, depression, and daytime function.

Sarsour K, Van Brunt DL, Johnston JA, Foley KA, Morin CM, Walsh JK.

Sleep Med. 2010 Dec;11(10):965-72. doi: 10.1016/j.sleep.2010.08.007. Epub 2010 Nov 18.

PMID:
21093365
39.

Pharmacotherapy for insomnia.

Feren S, Schweitzer PK, Walsh JK.

Handb Clin Neurol. 2011;99:747-62. doi: 10.1016/B978-0-444-52007-4.00005-9. No abstract available.

PMID:
21056226
40.

Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss.

Walsh JK, Hall-Porter JM, Griffin KS, Dodson ER, Forst EH, Curry DT, Eisenstein RD, Schweitzer PK.

Sleep. 2010 Sep;33(9):1217-25.

41.

Subtypes of sleep disturbance: associations among symptoms, comorbidities, treatment, and medical costs.

Foley KA, Sarsour K, Kalsekar A, Walsh JK.

Behav Sleep Med. 2010;8(2):90-104. doi: 10.1080/15402001003622842.

PMID:
20352545
42.

Enhancement of slow wave sleep: implications for insomnia.

Walsh JK.

J Clin Sleep Med. 2009 Apr 15;5(2 Suppl):S27-32. Review. No abstract available.

43.

Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.

Walsh JK, Salkeld L, Knowles LJ, Tasker T, Hunneyball IM.

Sleep Med. 2010 Jan;11(1):23-30. doi: 10.1016/j.sleep.2009.07.012. Epub 2009 Nov 28.

PMID:
19945340
44.

Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.

Czeisler CA, Walsh JK, Wesnes KA, Arora S, Roth T.

Mayo Clin Proc. 2009 Nov;84(11):958-72. doi: 10.1016/S0025-6196(11)60666-6.

45.

Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.

Dijk DJ, James LM, Peters S, Walsh JK, Deacon S.

J Psychopharmacol. 2010 Nov;24(11):1613-8. doi: 10.1177/0269881109105788. Epub 2009 Jun 1.

PMID:
19487320
46.

Association of insomnia severity and comorbid medical and psychiatric disorders in a health plan-based sample: Insomnia severity and comorbidities.

Sarsour K, Morin CM, Foley K, Kalsekar A, Walsh JK.

Sleep Med. 2010 Jan;11(1):69-74. doi: 10.1016/j.sleep.2009.02.008. Epub 2009 May 1.

PMID:
19410512
47.

The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.

Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.

Sleep Med. 2009 Sep;10(8):859-64. doi: 10.1016/j.sleep.2008.10.005. Epub 2009 Mar 31.

PMID:
19345644
48.

Nocturia and disturbed sleep in the elderly.

Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK.

Sleep Med. 2009 May;10(5):540-8. doi: 10.1016/j.sleep.2008.04.002. Epub 2008 Aug 13.

49.

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.

Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK.

J Clin Sleep Med. 2008 Jun 15;4(3):229-34.

50.

Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction.

Walsh JK, Snyder E, Hall J, Randazzo AC, Griffin K, Groeger J, Eisenstein R, Feren SD, Dickey P, Schweitzer PK.

Sleep. 2008 May;31(5):659-72.

Supplemental Content

Loading ...
Support Center